Skip to main content
. 2017 May 28;7(2):29. doi: 10.3390/diagnostics7020029

Figure 4.

Figure 4

Nanoparticle tracking analysis (NTA) distribution of an antibody-conjugated gold nanoparticle preparation, which is approximately 90% monomeric/10% dimeric.